Canada Markets closed

Biogen Inc. (BIIB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
264.80-5.41 (-2.00%)
At close: 4:00PM EDT
264.40 -0.40 (-0.15%)
After hours: 07:21PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close270.21
Open269.38
Bid264.20 x 900
Ask269.50 x 800
Day's Range264.35 - 270.37
52 Week Range223.25 - 468.55
Volume873,344
Avg. Volume982,093
Market Cap39.867B
Beta (5Y Monthly)0.39
PE Ratio (TTM)13.73
EPS (TTM)19.29
Earnings DateOct. 19, 2021 - Oct. 25, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est417.70
  • Motley Fool

    3 Big Problems With Biogen's Q3 Results

    Biogen (NASDAQ: BIIB) announced its third-quarter results on Wednesday. It's certainly true that Biogen did top analysts' estimates on both the top and bottom lines. Instead, there were three big problems with Biogen's Q3 results.

  • Motley Fool

    Why Ionis Pharmaceuticals Stock Is Down 13% This Week

    Shares of Ionis Pharmaceuticals (NASDAQ: IONS), a biotechnology company, have fallen around 13.6% since their closing price on Friday, Oct. 15, 2021. Investors were disappointed by phase 3 clinical trial results for tofersen, an experimental treatment for amyotrophic lateral sclerosis. Treatment with tofersen was supposed to help reduce physical symptoms of ALS, a progressive neurodegenerative disorder that affects around 20,000 new U.S. patients annually.